Target intelligence / Profile preview

Small G protein signaling modulator 1 (SGSM1)

Target
SGSM1
Molecular classification
Other, RUN domain-containing protein, TBC (Tre-2/Bub2/Cdc16) domain-containing protein
01

Overview

Small G protein signaling modulator 1 (SGSM1) is a cytosolic and cytoplasmic vesicle-associated protein primarily expressed in the central nervous system, containing RUN and TBC1 domains[1][2][7]. SGSM1 functions as a modulator of small GTPase signaling, acting as both an effector and GTPase activator for various members of the Rab and Rap family of small G proteins, particularly promoting GTP hydrolysis by RAB34 and RAB36, but not RAB9A and RAB9B[1][7][2]. It is involved in intracellular signal transduction and vesicular trafficking, and influences pathways such as positive regulation of transcription by RNA polymerase II[1][2]. Mutations or genetic variation in SGSM1 have been associated with certain neurodegenerative disorders, but it is not currently established as a direct therapeutic target[1]. The canonical gene and protein name, as defined in gene/protein databases, is "Small G protein signaling modulator 1," with SGSM1 as its widely accepted abbreviation[1][2][4]. The primary molecular features are the RUN and TBC1 domains, placing it in the broad "Other" molecular classification; these domains relate to small GTPase regulatory mechanisms, but SGSM1 is not an enzyme, traditional receptor, transporter, or channel[2][7][10]. SGSM1 is a cytosolic protein involved in vesicle transport through Rab and Rap GTPase pathways, contributing to membrane trafficking necessary for neuronal and other cellular functions[1][2][7]. There is no evidence in the provided data or current research databases of direct drug interactions, biomarker status, therapeutic mechanism, or safety issues—nor is it currently a typical small-molecule drug target[1][2][4]. Genetic mutations in SGSM1 have been associated with rare inherited neurological disorders such as autosomal dominant adult-onset proximal spinal muscular atrophy and autosomal recessive spastic paraplegia 57[1]. Aliases are consistent across major genomic and protein resources and include all names listed in the query[1][2][4]. No evidence of misspelling, incorrectness, or inappropriateness as a protein/gene target (SGSM1 is a valid, well-characterized protein-coding gene)[1][2][4][9].

Other names
Small G protein signaling modulator 1SGSM1KIAA1941RUTBC2RUN and TBC1 domain-containing protein 2RUN and TBC1 domain containing 2small G protein signaling modulator 1 proteinnurr1-interacting protein (NuIP)
02

Biological functions

GTPase activator activitySmall GTPase bindingPositive regulation of transcription by RNA polymerase IISignal transductionVesicle transport regulation
03

Disease associations

Neurodegenerative disease (notably, "autosomal dominant adult-onset proximal spinal muscular atrophy")Spastic paraplegiaOther (no strong, widely validated association with major disease categories like cancer or cardiovascular disease)

Beyond the preview

Go deeper on Small G protein signaling modulator 1 (SGSM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small G protein signaling modulator 1 (SGSM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call